DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Busulfan
Busulfan
Label (PDF)
Arsenic Trioxide As a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
Busulfan–Melphalan Followed by Autologous Stem Cell
An Evaluation of Engraftment, Toxicity and Busulfan Concentration in Children Receiving Bone Marrow Transplantation for Leukemia Or Genetic Disease
Mitomycin C in the Treatment of Chronic Myelogenous Leukemia
Standard Oncology Criteria C16154-A
Cardio-Oncology: Basics and Knowing When You Need an Echo
Conditioning Regimens Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in Infants: Clinical and Pharmacokinetic Results
Induction of Sister Chromatid Exchanges and Chromosomal Aberrations by Busulfan in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia and Normal Bone Marrow1
Thiotepa, Busulfan, and Cyclophosphamide Or Busulfan
Cancer Drug Costs for a Month of Treatment at Initial Food
CNS Relapse in Acute Promyeloctyic Leukemia
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
MYLERAN® (Busulfan) 2-Mg Scored Tablets
High-Dose Busulfan, Melphalan and Thiotepa Followed by Autologous Peripheral Blood Stem Cell (PBSC) Rescue in Patients with Advanced Stage III/IV Ovarian Cancer
FLUDARABINE-METHOTREXATE (Gvhd)
Allogeneic Stem Cell Transplantation (BMT) for AML and MDS Following Iv Busulfan and Cyclophosphamide
Busulfan Information and a Dv Ice Supporting Patients MPN Voice and Families Affected Previously Known As MPD Voice by MPN
Top View
Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course
Inflammatory High-Risk Breast Cancer
Seizures and Syncope in the Cancer Patient
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
Busulfan (Myleran®) (“Byoo SUL Fan”)
Long-Term and Low-Dose of Busulfan Is a Safe and Effective Second-Line
Clinical Implications for Cediranib in Advanced Cervical Cancer
Emetogenic Potential of Antineoplastic Agents
DRUG NAME: Busulfan
Chemical Compatibility of Chemoclave™ and Chemolock™
Pharmacogenetic Analysis of Liver Toxicity After Busulfan/Cyclophosphamide-Based Allogeneic Hematopoietic Stem Cell Transplantation
A Phase IIA Study of the Addition of Temozolomide
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth Yulian P
The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye
List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
Trisenox, INN-Arsenic Trioxide
Emetogenic Potential of Antineoplastic Agents
Pharmaceuticals Utilized in Stem Cell Transplant